Cristin-prosjekt-ID: 2063581
Registrert av: REK Sist endret: 10. september 2020, 13:26

Cristin-prosjekt-ID: 2063581
Registrert av: REK Sist endret: 10. september 2020, 13:26
Prosjekt

SeroSelectTB

prosjektleder

Carol Joanne Church Holm-Hansen
ved Smittevern, miljø og helse ved Folkehelseinstituttet

prosjekteier / koordinerende forskningsansvarlig enhet

  • Folkehelseinstituttet

Godkjenninger

  • Regionale komitéer for medisinsk og helsefaglig forskningsetikk (REK) - 60638

Kategorier

Helseprosjekttype

Annet studium

Tidsramme

Aktivt
Start: 1. januar 2020 Slutt: 31. desember 2023

Beskrivelse Beskrivelse

Tittel

SeroSelectTB

Populærvitenskapelig sammendrag

The performance of a new triage test for active tuberculosis, SeroSelectTB, will be qualified in multi-centre randomised controlled trials at health-posts in South Africa, Tanzania and Ethiopia. Cost effectiveness evaluations will be conducted to support a value proposition to stakeholders and regulatory authorities, and to support commercialization requirements. Consenting adults will provide blood and saliva samples for screening by SeroSelectTB, and sputum collected for routine TB diagnosis by the health services. Clinical and sociodemographic information will be collected. A reliable rapid test will make it possible to identify and selectively treat those with active TB at the local healthcare level. The expected impact includes accurate same-day diagnosis of patients with active TB, reduction of diagnostic delay and TB transmission, and diagnostic cost-savings for patients and healthcare systems in high burden countries.

SeroSelectTB is a multinational project coordinated by the Norwegian Institute of Public Health (Oslo, Norway). Partners include Stellenbosch University and Lateral Flow Laboratories (South Africa), Kilimanjaro Christian Medical University College (Tanzania), Armauer Hansen Research Institute (Ethiopia), National Institute for Public Health and the Environment (Netherlands), InVivo Biotech Services GmbH (Germany), Aether Dynamics Consulting & Trading GmbH (Austria), and E-MEDDIA (France).

Tittel

SeroSelectTB

Populærvitenskapelig sammendrag

The performance of a new triage test for active tuberculosis, SeroSelectTB, will be qualified in multi-centre randomised controlled trials at health-posts in South Africa, Tanzania and Ethiopia. Cost effectiveness evaluations will be conducted to support a value proposition to stakeholders and regulatory authorities, and to support commercialization requirements. Consenting adults will provide blood and saliva samples for screening by SeroSelectTB, and sputum collected for routine TB diagnosis by the health services. Clinical and sociodemographic information will be collected. A reliable rapid test will make it possible to identify and selectively treat those with active TB at the local healthcare level. The expected impact includes accurate same-day diagnosis of patients with active TB, reduction of diagnostic delay and TB transmission, and diagnostic cost-savings for patients and healthcare systems in high burden countries.

SeroSelectTB is a multinational project coordinated by the Norwegian Institute of Public Health (Oslo, Norway). Partners include Stellenbosch University and Lateral Flow Laboratories (South Africa), Kilimanjaro Christian Medical University College (Tanzania), Armauer Hansen Research Institute (Ethiopia), National Institute for Public Health and the Environment (Netherlands), InVivo Biotech Services GmbH (Germany), Aether Dynamics Consulting & Trading GmbH (Austria), and E-MEDDIA (France).

prosjektdeltakere

prosjektleder

Carol Joanne Church Holm-Hansen

  • Tilknyttet:
    Prosjektleder
    ved Smittevern, miljø og helse ved Folkehelseinstituttet

Tara Kelly Dolgner

  • Tilknyttet:
    Prosjektdeltaker
    ved Avdeling for forskningsadministrativ støtte ved Folkehelseinstituttet

Ida Laake

  • Tilknyttet:
    Prosjektdeltaker
    ved Smittevern, miljø og helse ved Folkehelseinstituttet

Grant Theron

  • Tilknyttet:
    Prosjektdeltaker
    ved University of Stellenbosch

Anna Ojo

  • Tilknyttet:
    Prosjektdeltaker
    ved University of Stellenbosch
1 - 5 av 13 | Neste | Siste »